Med BioGene Inc
Research Med BioGene Inc (MBI-H) on Bullrun: market cap CAD 345.16K. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMBI-H
- ExchangeV
- CountryCanada
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyCAD
- Market capCAD 345.16K
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 8.87K
- Free cash flow-USD 7.28K
Valuation Snapshot
latest market cap is CAD 345.16K.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 46.49K | -USD 44.26K | n/a | n/a | USD 100 | n/a | -USD 224.11K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | CAD 345.16K | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Med BioGene Inc
Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It also focuses on the commercialization of technologies in various industrial sectors. The company is headquartered in Vancouver, Canada.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Med BioGene Inc's market cap?
Med BioGene Inc's market capitalization is CAD 345.16K.
What does Med BioGene Inc do?
Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It also focuses on the commercialization of technologies in various industrial sectors. The company is headquartered in Vancouver, Canada.